Dey Adds New Vice President of Marketing, Focuses on Product Portfolio


Napa, CA, April 25, 2002 - Dey L.P., a specialty pharmaceutical company based in Napa, announces the addition of Raymond Joske, vice president of marketing.

Joske brings to Dey over 16 years of healthcare, pharmaceutical marketing and pharmaceutical sales experience. His background covers a broad spectrum of the healthcare industry; he has directed a healthcare marketing consulting group, RJSynergy, managed branded products for Bristol-Myers Squibb in the neuroscience area, and developed strategy for medical publishing at Harcourt Health Sciences. He holds an MBA from Saint Mary’s College of California and a bachelor’s from California State University, Northridge.

Joske’s primary role at Dey will be to lead the marketing team, manage Dey’s current portfolio of branded and generic products and prepare for new product offerings in coming years.

“The addition of Ray is indicative of Dey executing its strategic plans to shift the business of the company from primarily generic products to branded products. Ray’s background and expertise are ideally suited to the needs of Dey both now and in the future,” explained Mel Engle, chief operating officer at Dey.

Dey’s focus on providing patients with high quality, affordable health care solutions through its generic and branded product lines has expanded the company’s presence within the pharmaceutical industry.

About Dey, L.P.

Dey, L.P., is a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for the treatment of respiratory diseases and respiratory-related allergies. Since 1978, patients have benefited from Dey's commitment to innovative and affordable health care solutions.The Web sites for DEY include www.dey.com, www.accuneb.com, www.curosurfusa.com, www.duoneb.com and www.epipen.com. Dey is an associate of Merck KGaA, Darmstadt, Germany

.

###

Contact: Dey, L.P. Media Line 1-800-755-5560 ext. 8363



< Back to Press Releases
 
<< Back to Press Room